Literature DB >> 34322306

Evaluation of spirometry findings with severity of coronary artery disease in smoker patients undergoing angiography in military hospital during 2019-2020.

Milad Kabiri Samani1, Seyed Hossein Mosavi2, Reza Arefizadeh2.   

Abstract

BACKGROUND: Coronary heart disease is the most common cardiovascular worldwide, and some factors can affect the prognosis of this disease. So, in this study, we aimed to examine the relationship between spirometry and cardiovascular risk factors in patients undergoing coronary angiography who were referred to military hospitals.
METHODS: In this cross-sectional study, 200 smokers referred to military hospital for angiography, were enrolled in terms of the inclusion and exclusion criteria between 2019 and 2020. The severity of the coronary artery involvement was determined using Gensini score. The relationship among spirometry and the forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and FEV1/FVC with other variables including lipid profile, demographic findings, blood pressure, physical activity, and severity of coronary artery involvement were also exanimated.
RESULTS: The frequency of severity of coronary involvement were reported as 3.5% with 25% involvement, 7% with 26-50% involvement, 5.5% with 51-75% involvement, 27.5% with 76-90% involvement, 47% with 91-99% involvement, and 9.5% with 100% involvement. In addition, there was no significant relationship between severity of coronary involvement and FEV1 and FVC (P>0.05). However, there was a significant difference between the groups based on FEV1/FVC (P=0.003), in which the mean of FEV1/FVC was significantly lower in higher severity of coronary involvement compared to lower severity of coronary involvement. There were significant relationships between severity of coronary involvement and body mass index, fasting blood sugar, high-density lipoprotein and low-density lipoprotein, cholesterol, triglyceride, waist circumference, systolic blood pressure, diastolic blood pressure, physical activity, and smoking (P<0.05).
CONCLUSION: There is an association between pulmonary diseases and coronary disease, in which the increased coronary involvement severity is associated with the decreased FEV1/FVC. AJCD
Copyright © 2021.

Entities:  

Keywords:  Coronary artery disease; pulmonary diseases; pulmonary function test

Year:  2021        PMID: 34322306      PMCID: PMC8303042     

Source DB:  PubMed          Journal:  Am J Cardiovasc Dis        ISSN: 2160-200X


  20 in total

1.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

2.  Lung function and cardiovascular risk: effect of cardiac rehabilitation.

Authors:  David A Kaminsky; Patrick D Savage; Peter W Callas; Philip A Ades
Journal:  J Cardiopulm Rehabil Prev       Date:  2010 Nov-Dec       Impact factor: 2.081

3.  Coronary artery calcium score and risk classification for coronary heart disease prediction.

Authors:  Tamar S Polonsky; Robyn L McClelland; Neal W Jorgensen; Diane E Bild; Gregory L Burke; Alan D Guerci; Philip Greenland
Journal:  JAMA       Date:  2010-04-28       Impact factor: 56.272

4.  Coronary artery calcium to predict all-cause mortality in elderly men and women.

Authors:  Paolo Raggi; Maria C Gongora; Ambarish Gopal; Tracy Q Callister; Matthew Budoff; Leslee J Shaw
Journal:  J Am Coll Cardiol       Date:  2008-07-01       Impact factor: 24.094

5.  Relationship between chronic obstructive pulmonary disease and subclinical coronary artery disease in long-term smokers.

Authors:  Thomas Rasmussen; Lars Køber; Jesper Holst Pedersen; Asger Dirksen; Laura Hohwü Thomsen; Steen Stender; John Brodersen; Jaap Groen; Haseem Ashraf; Klaus Fuglsang Kofoed
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2013-05-02       Impact factor: 6.875

6.  Association of lung function with cardiovascular risk: a cohort study.

Authors:  Bin Wang; Yun Zhou; Lili Xiao; Yanjun Guo; Jixuan Ma; Min Zhou; Tingming Shi; Aijun Tan; Jing Yuan; Weihong Chen
Journal:  Respir Res       Date:  2018-11-06

7.  Lung Function in Young Adults and Risk of Cardiovascular Events Over 29 Years: The CARDIA Study.

Authors:  Michael J Cuttica; Laura A Colangelo; Mark T Dransfield; Surya P Bhatt; Jamal S Rana; David R Jacobs; Bharat Thyagarajan; Stephen Sidney; Cora E Lewis; Kiang Liu; Donald Lloyd-Jones; George Washko; Ravi Kalhan
Journal:  J Am Heart Assoc       Date:  2018-12-18       Impact factor: 5.501

8.  Spirometry in patients screened for coronary artery disease: is it useful?

Authors:  Frederico Leon Arrabal Fernandes; Regina Maria Carvalho-Pinto; Rafael Stelmach; João Marcos Salge; Carlos Eduardo Rochitte; Eliane Cardoso Dos Santos Souza; Janaina Danielle Pessi; Alberto Cukier
Journal:  J Bras Pneumol       Date:  2018 Jul-Aug       Impact factor: 2.624

Review 9.  Influence of sex hormones and phytoestrogens on heart disease in men and women.

Authors:  Poornima Bhupathy; Christopher Dean Haines; Leslie Anne Leinwand
Journal:  Womens Health (Lond)       Date:  2010-01

10.  Population and mortality profile in the Islamic Republic of Iran, 2006-2035.

Authors:  Saeide Aghamohamadi; Kamran Hajinabi; Katayoun Jahangiri; Iravan Masoudi Asl; Reza Dehnavieh
Journal:  East Mediterr Health J       Date:  2018-07-17       Impact factor: 1.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.